Features of autoimmunity in the abdominal aortic aneurysm

Archives of Surgery

Volumn 131, Issue 1, 1996, Pages 85-88

  Gregory, Anita K ^a   Yin, Nancy X ^a   Capella, Joseph ^a   Xia, Simon ^a   Newman, Karen M ^a   Tilson, M David ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ANTIBODY PRODUCTION; AORTA WALL; ARTICLE; AUTOIMMUNITY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN PURIFICATION;

EID: 0030038874     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430130087017     Document Type: Article

References (16)

1. Beckman EN. Plasma cell infiltrates in abdominal aortic aneurysm Am J Clin Pathol 1986;85:21-24
2. Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990,137:1199-1219.
3. Brophy CM, Reilly JM, Smith GJW, Tilson MD. The role of inflammation in non-specific abdominal aortic aneurysm disease Ann Vasc Surg. 1991.5:229-233
4. Newman KM, Jean-Claude J, Li H, et al Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 1994;20:814-820
5. Newman KM, Ogata Y, Malon AM, et al. Identification of matrix metalloproteinases 3 (Stromelysin-1) and 9 (Gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1994;14 1315-1320
6. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD. Matrix metalloproteinases in abdominal oartic aneurysm: characterization, purification, and their possible sources Connect Tissue Res 1994;30:265-276.
7. Pearce WH, Sweis I, Yao JST, McCarthy WJ, Koch AE. Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J Vasc Surg. 1992,16.784-789.
8. Tilson MD, Newman KM. Proteolytic mechanisms in the pathogenesis of aortic aneurysms. In: Yao JST, Pearce WH, eds. Aneurysms: New Findings and Treatments Norwalk, Conn: Appleton & Lange 1994:3-9.
9. Newman KM, Johnson CL, Jean-Claude J, Li H, Ramey WG, Tilson MD. Cytokines which activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 1994.90(part 2):224-227.
10. Hingorani A, Newman K, Gregory A, Yin N, Tilson MD. A soluble extract from abdominal aortic aneurysm wall stimulates protein secretion and gelatinase expression in cultured macrophage-like cells (U937). Surg Forum. 1994;45 375-377
11. Herron GS, Unemon E, Wong M, et al Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 1991, 11.1667-1677.
12. Newman KM, Jean-Claude J, Li H, et al. Cellular localization of matrix metaltoproteinases in the abdominal aortic aneurysm wall. J Vasc Surg. In press
13. Brophy CM, Smith GJW, Tilson MD Pathology of nonspecific abdominal aortic aneurysm disease In: Ernst CB, Stanley JC, eds, Current Therapy in Vascular Surgery. 2nd ed Philadelphia, Pa. BC Decker Inc: 1991:238-241.
14. Holmes DR, Liao S, Parks WC, Thompson RW. Medial neovascularization in AAA, a histopathologic marker of aneurysmal degeneration with pathophysiological implications J Vasc Surg. 1995;21:761-772.
15. Tilson MD, Elefteriades J, Brophy CM. Tensile strength and collagen in abdominal aortic aneurysms. In: Greenhalgh RM, Mannick JA, eds. The Cause and Management of Aneurysms. Philadelphia, Pa: WB Saunders Co: 1990;97-104
16. Trentham DE, Dynesius-Trentnam RA, Oran EJ, et al Effects of oral administration of type II collagen on rheumatoid arthritis Science. 1993;261:1727-1730.